Pathkey.AI Ltd (ASX:PKY)
0.0240
+0.0020 (9.09%)
At close: Aug 27, 2025
Pathkey.AI Company Description
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia.
The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions.
It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations.
The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025.
Pathkey.AI Ltd was incorporated in 1994 and is based in Milsons Point, Australia.
Pathkey.AI Ltd
Country | Australia |
Founded | 1994 |
Industry | Metal Mining |
CEO | Saurabh Jain |
Contact Details
Address: 6 Middlemiss Street Milsons Point, 2061 Australia | |
Website | opyl.ai |
Stock Details
Ticker Symbol | PKY |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
SIC Code | 1000 |
Key Executives
Name | Position |
---|---|
Saurabh Jain | Chief Executive Officer |
Mark Ziirsen | Chief Financial Officer |